5-androstenedione
← Previous: 5-alpha-hydroxy-laxogenin | 🏠 All Substances | 📊 Complete Table | Next: 5-fluoro-PB-22 →
OPSS Properties
| Classifications | 6000 |
| DEA Schedule | Schedule III |
| Also Known As |
|
| Prohibited Because | DEA Controlled Substance List: Schedule III (DEA Controlled Substance List: Schedule III) WADA S1: Anabolic Agents (WADA Prohibited List S1: Anabolic Agents) |
| Added to Database | December 30, 2025 |
| Source Last Updated | May 28, 2024 |
| GUID | 4a7abba9-d2cb-42f1-8cfa-50b9d00c1dd2 |
External Resources
- FDA UNII Search
- GSRS Full Record
- NCATS Inxight Drugs
- CAS Common Chemistry
- PubChem
- EPA CompTox Dashboard
UNII: HEE11L5C3G · CAS: 571-36-8
PubChem Properties
Chemical Structure
Interactive 3D Structure
| Molecular Formula | C19H26O2 |
| Molecular Weight | 286.4 g/mol |
| IUPAC Name | (8R,9S,10R,13S,14S)-10,13-dimethyl-2,4,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione |
| InChIKey | SQGZFRITSMYKRH-QAGGRKNESA-N |
📊 Complete Table | 🏠 All Substances
Substance 95 of 880